Supplementary information

Similar documents
Mechanisms of resistance to JAK inhibitors. L. Knoops

Supplementary Information. Targeting BRK-positive Breast Cancer with Small

Pyk2 activates the NLRP3 inflammasome by directly phosphorylating ASC and contributes to inflammasome-dependent peritonitis

For Simultaneously Detecting the Relative Level of Tyrosine Phosphorylation of Human Receptor Tyrosine Kinases (RTKs).

Type of file: PDF Title of file for HTML: Supplementary Information Description: Supplementary Figures

Overcoming Resistance to HER2 Inhibitors Through State-Specific Kinase Binding

Content Prioritization And Content Entry and Quality Control Process

Doctoral Degree Program in Marine Biotechnology, College of Marine Sciences, Doctoral Degree Program in Marine Biotechnology, Academia Sinica, Taipei,

Supplementary Video 1. Loss of MitoTracker in WT BMDM. WT BMDM were LPS primed

Supplementary Materials for

Supplemental Table 1. Biochemical and Cellular Potency and Selectivity of PF

Supplemental Table S1: Inhibition of HDAC class I and class II family by CUDC-101 (IC50 in nm)

Incorporation of photo-caged lysine (pc-lys) at K273 of human LCK allows specific control of the enzyme activity.

SUPPLEMENTARY FIGURES

LPS LPS P6 - + Supplementary Fig. 1.

Activation of Nrf2 by the dengue virus causes an increase in CLEC5A, which enhances TNF-α production by mononuclear phagocytes

SUPPLEMENTARY INFORMATION

Supplementary Data Figure S1. A) PKI-587 suppression of p-akt in A498 and (+/- 10

Supplemental text file, including:

SUPPLEMENTARY INFORMATION

VOICES OF THE HIDDEN

Supplementary information

Supplementary Material

International Conference on Biomedical and Biological Engineering (BBE 2016)

Origin of oncogenes? Oncogenes and Proto-oncogenes. Jekyll and Hyde. Oncogene hypothesis. Retroviral oncogenes and cell proto-oncogenes

WT Xid (h) poly(da:dt) Alum. Poly(dA:dT) 0.05

Supplementary Table 1. In vitro side effect profiling study for LDN/OSU

Supplementary information S1 (table): Specifications of individual protein protein interactions within the Cbl and Cbl-b interactomes

Integrin CD11b negatively regulates TLR-triggered inflammatory responses by. activating Syk and promoting MyD88 and TRIF degradation via cbl-b

Supplementary Figure 1: Tissue of Origin analysis on 152 cell lines. (a) Heatmap representation of the 30 Tissue scores for the 152 cell lines.

VEGFR. 1

How to compute a semantic similarity threshold. Charles Bettembourg, Christian Diot, Olivier Dameron

Regulatory Status FDA-approved indication: Cabometyx is a kinase inhibitor indicated for the treatment of advanced renal cell carcinoma (1).

The Current Champion: Angiogenesis inhibitors

Dynamic Interaction of Stress Granule, DDX3X and IKK-α Mediates Multiple Functions in

Protein tyrosine kinase signaling

Brigatinib overcomes ALK resistance mechanisms preclinically Zhang et al Supplementary information

Fluxion Biosciences and Swift Biosciences Somatic variant detection from liquid biopsy samples using targeted NGS

Supporting Information For

Trehalose, sucrose and raffinose are novel activators of autophagy in human. keratinocytes through an mtor-independent pathway

CURRICULUM VITAE Name : Gender : Birth Place : address : Contact Tel : Education: Training and Working Experiences: Awards:

Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines

(a) Significant biological processes (upper panel) and disease biomarkers (lower panel)

B16F1 B16F10 Supplemental Figure S1

Supplementary Information

Staurosporine Tethered Peptide Ligands for camp-dependent Protein Kinase A (PKA): Optimization and Selectivity Profiling

DMSO GNF7156 GNF4877 DA/ U Ed/ nilusni M o u s e b e t a c e l l p r o li f e r a t i o n GNF4877 G N F G N F Ki6 e 3

Regorafenib from Bayer Submitted to Health Authorities Seeking Approval in Second-Line Treatment of Liver Cancer

(A) RT-PCR for components of the Shh/Gli pathway in normal fetus cell (MRC-5) and a

Supplementary Appendix

Comparison of Triple Negative Breast Cancer between Asian and Western Data Sets

Refining Prognosis of Early Stage Lung Cancer by Molecular Features (Part 2): Early Steps in Molecularly Defined Prognosis

Downregulation of the small GTPase SAR1A: a key event underlying alcohol-induced Golgi fragmentation in hepatocytes

Fig.1 Physicochchemical characterization of LDH nanoparticles and 5-FU/LDH nanocomplex.

Journal of Chinese Medicine. Vol.20, No.1, Vol.20, No.3,

human epithelial cells were pretreated with control sirna (50 nm) or GSK-3β sirna (50 nm)

Fang et al. NMuMG. PyVmT unstained Anti-CCR2-PE MDA-MB MCF MCF10A

Supplementary Materials for

50 nmoles substrate. 8,000 Test Points based on 100 nm in reaction

were isolated from the freshly drawn blood of healthy donors and ACS patients using the

Supplementary Information

Howard Temin. Predicted RSV converted its genome into DNA to become part of host chromosome; later discovered reverse transciptase.

Supplementary Figure 1. Characterization of NMuMG-ErbB2 and NIC breast cancer cells expressing shrnas targeting LPP. NMuMG-ErbB2 cells (a) and NIC

The antibodies against 5-bromo-2 -deoxyuridine specifically recognize

A dual PI3 kinase/mtor inhibitor reveals emergent efficacy in glioma

Blocking c-met mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors

Supplementary Figure 1. Identification of tumorous sphere-forming CSCs and CAF feeder cells. The LEAP (Laser-Enabled Analysis and Processing)

Protein tyrosine phosphatase 1B targets PITX1/p120RasGAP. thus showing therapeutic potential in colorectal carcinoma

c Ischemia (30 min) Reperfusion (8 w) Supplementary Figure bp 300 bp Ischemia (30 min) Reperfusion (4 h) Dox 20 mg/kg i.p.

Impact factor: Reporter:4A1H0019 Chen Zi Hao 4A1H0023 Huang Wan ting 4A1H0039 Sue Yi Zhu 4A1H0070 Lin Guan cheng 4A1H0077 Chen Bo xuan

Hsin-Pai Li ( 黎欣白 ) School: University of Southern California/ USA (Department of Microbiology)

SUPPLEMENTARY FIGURES

Supplemental Information. Lck/Hck/Fgr-Mediated Tyrosine. Phosphorylation Negatively Regulates. TBK1 to Restrain Innate Antiviral Responses

IntelliGENSM. Integrated Oncology is making next generation sequencing faster and more accessible to the oncology community.

A Hepatocyte Growth Factor Receptor (Met) Insulin Receptor hybrid governs hepatic glucose metabolism SUPPLEMENTARY FIGURES, LEGENDS AND METHODS

Supplementary Figure 1.TRIM33 binds β-catenin in the nucleus. a & b, Co-IP of endogenous TRIM33 with β-catenin in HT-29 cells (a) and HEK 293T cells

Concomitant WT1 mutations predicted poor prognosis in CEBPA double-mutated acute myeloid leukemia

GFP-LC3 +/+ CLU -/- kda CLU GFP. Actin. GFP-LC3 +/+ CLU -/- kda CLU GFP. Actin

Hirsutella sinensis mycelium attenuates bleomycininduced pulmonary inflammation and fibrosis in vivo

Tumor inflammasome-derived IL-1β recruits neutrophils and improves local recurrence-free survival in EBV-induced nasopharyngeal carcinoma

Supplementary Materials for

Blood Plasma Separation Using a Fidget-Spinner

Specific polyunsaturated fatty acids modulate lipid delivery and oocyte development in C. elegans revealed by molecular-selective label-free imaging

SUPPLEMENTARY INFORMATION. Supplementary Figures S1-S9. Supplementary Methods

Figure S1. PMVs from THP-1 cells expose phosphatidylserine and carry actin. A) Flow

NanoBRET: A Quantitative Technique to Measure Kinase Target Engagement in Live Cells Matthew Robers

Li et al. Journal of Experimental & Clinical Cancer Research (2018) 37:108

COMETRIQ (cabozantinib) oral capsule

Characteristics of Taiwanese patients of PNH in the international PNH registry

SUPPLEMENTARY INFORMATION

Argininosuccinate synthetase 1 suppression and arginine restriction inhibit cell

Rescue of mutant rhodopsin traffic by metformin-induced AMPK activation accelerates photoreceptor degeneration Athanasiou et al

p = formed with HCI-001 p = Relative # of blood vessels that formed with HCI-002 Control Bevacizumab + 17AAG Bevacizumab 17AAG

Mice. Mice genetically deficient for IRAK-1, IRAK-2, IRAK-1/2, MyD88, TRIF, NLRP3,

Understanding the Role of the Inflammasome in Inflammation

Dr David Guttery Senior PDRA Dept. of Cancer Studies and CRUK Leicester Centre University of Leicester

Role of Non Receptor Tyrosine Kinases in Hematological Malignances and its Targeting by Natural Products

CD14 + S100A9 + Monocytic Myeloid-Derived Suppressor Cells and Their Clinical Relevance in Non-Small Cell Lung Cancer

Supplementary Figure 1: Expression of NFAT proteins in Nfat2-deleted B cells (a+b) Protein expression of NFAT2 (a) and NFAT1 (b) in isolated splenic

Targeted Agent and Profiling Utilization Registry (TAPUR ) Study. February 2018

Transcription:

Supplementary information Pyk2 activates the NLRP3 inflammasome by directly phosphorylating ASC and contributes to inflammasome-dependent peritonitis I-Che Chung 1, Chun-Nan OuYang 1, Sheng-Ning Yuan 1, Hsin-Pai Li 2,3,4, Jeng-Ting Chen 1, Hui-Ru Shieh 5, Yu-Jen Chen 5,6, David M. Ojcius 7, Ching-Liang Chu 8, Jau-Song Yu 3,9,10, Yu-Sun Chang 1,3,11, Lih-Chyang Chen 12,* 1 Molecular Medicine Research Center, Chang Gung University, 333 Taoyuan, Taiwan 2 Department of Microbiology and Immunology, Chang Gung University, 333 Taoyuan, Taiwan 3 Graduate Institute of Biomedical Sciences, Chang Gung University, 333 Taoyuan, Taiwan 4 Division of Hematology-Oncology, Chang Gung Memorial Hospital at Lin-Kuo, 333 Taoyuan, Taiwan 5 Department of Medical Research Mackay Memorial Hospital, 251 New Taipei City, Taiwan 6 Department of Radiation Oncology, Mackay Memorial Hospital, 251 New Taipei City, Taiwan 7 Department of Biomedical Sciences, University of the Pacific Arthur A. Dugoni School of Dentistry, San Francisco, CA 94103, USA 8 Graduate Institute of Immunology, College of Medicine, National Taiwan University, 100 Taipei, Taiwan 9 Proteomics Core Laboratory, Chang Gung University, 333 Taoyuan, Taiwan 10 Liver Research Center, Chang Gung Memorial Hospital at Lin-Kou, 333 Taoyuan, Taiwan 11 Department of Otolaryngology, Chang Gung Memorial Hospital at Lin-Kuo, 333 Taoyuan, Taiwan 12 Department of Medicine, Mackay Medical College, 252 New Taipei City, Taiwan * Corresponding author: Lih-Chyang Chen, Department of Medicine, Mackay Medical College, 252 New Taipei City, Taiwan. Tel: 886-2-26360303 ext 1225, email: lihchyang@mmc.edu.tw

Supplementary materials and methods Lactate dehydrogenase (LDH) release assay LDH levels were measured in the supernatant using the LDH Cytotoxicity detection kit (TaKaRa Clontech). The assays were performed according to the manufacturer s instructions, and the red formazan product was measured at 490 nm using a SpectraMax M2 microplate reader (Molecular Devices). Measurements were performed at least in triplicate. Percent LDH release was calculated as follows: [(LDH sample)-(ldh negative control)]/[(ldh positive control)-(ldh negative control)]. LDH negative control for spontaneous LDH release was measured from untreated cells. LDH positive control for maximum LDH release was measured in cells lysed with 2% Triton-X-100. Measurements of speck sizes ASC speck images were randomly acquired under confocal microscopy using a Zeiss LSM510 META laser scanning microscope (Carl Zeiss, Germany) with a 63 1.32 NA oil immersion objective. Nuclei were stained with DAPI. The largest diameters of individual specks were measured.

Supplementary Figure S1. Release of LDH upon NLRP3 and AIM2 inflammasome activation. (A) Activity assay of LDH in the culture supernatant of PMA-differentiated THP-1 cells stimulated with ATP, MSU, nigericin, or poly(da:dt) in the presence or absence of the indicated kinase inhibitors. (B) Activity assay of LDH in the supernatant of PMA-differentiated THP-1 cells treated with Pyk2-, FAK-, or negative control (C) sirna, followed by stimulation with ATP, MSU, nigericin, or poly(da:dt). Two independent FAK sirna are indicated as FAK#1 and FAK#2. Symbols: *, P < 0.05; and **, P < 0.01. All results are presented as the mean ± SD of three independent experiments, and were analyzed with the Student s t test.

Supplementary Figure S2. Expression of pro-il-1β upon NLRP3 and AIM2 inflammasome activation. (A) Western blotting of pro-il-1β in the cell lysate of PMA-differentiated THP-1 cells stimulated with ATP, MSU, nigericin, or poly(da:dt) in the presence or absence of the indicated kinase inhibitors. (B) Western blotting of pro-il-1β in the cell lysate of PMA-differentiated THP-1 cells treated with Pyk2-, FAK-, or negative control (C) sirna, followed by stimulation with ATP, MSU, nigericin, or poly(da:dt). Two independent FAK sirna are indicated as FAK#1 and FAK#2. The western blot is a representative of three independent experiments.

Supplementary Figure S3. Inhibition of condensed ASC specks by PF-431396. Representative images of ASC-mCherry-expressing THP-1 cells stimulated with nigericin in the presence or absence of PF-431396 (PF-43) for 1 h. Measurement of the ASC speck diameter was shown in right panel. The numbers of specks measured were 100 and 103 and the median speck size as indicated. Nuclei were stained with DAPI. Scale bars, 10 mm. ***P<0.001 (one-way analysis of variance).

Table S1. Prediction of kinase-specific phosphorylation at ASC Tyr146 Protein kinase match Human Kinase Short Name Human UniProt. ID Kinase Predictor V2 Score Kinase 1: PYK2 (PTK2B) Q14289 463 Kinase 2: FAK Q05397 463 Kinase 3: BRK Q13882 457 Kinase 4: MET (HGF Receptor) P08581 457 Kinase 5: ZAP70 P43403 455 Kinase 6: CTK (MATK) P42679 448 Kinase 7: AXL P30530 442 Kinase 8: FER P16591 442 Kinase 9: FYN P06241 440 Kinase 10: SYK P43405 438 Kinase 11: KIT P10721 434 Kinase 12: MER (MERTK) Q12866 434 Kinase 13: YES1 P07947 434 Kinase 14: FGFR1 P11362 432 Kinase 15: SRC P12931 428 Kinase 16: CSK P41240 427 Kinase 17: HCK P08631 426 Kinase 18: ERBB3 P21860 424 Kinase 19: TYRO3 Q06418 421 Kinase 20: ERBB2 P04626 421 Kinase 21: PDGFRA P16234 420 Kinase 22: TEC P42680 418 Kinase 23: FGFR4 P22455 417 Kinase 24: ERBB4 Q15303 417 Kinase 25: ABL P00519 414 Kinase 26: FGFR2 P21802 413 Kinase 27: FGFR3 P22607 413 Kinase 28: ARG (ABL2) P42684 413 Kinase 29: FRK P42685 412 Kinase 30: FES P07332 412 Kinase 31: FGR P09769 409 Kinase 32: FLT1 P17948 407 Kinase 33: LYN P07948 406 Kinase 34: FMS (CSF1R) P07333 405 Kinase 35: RON Q04912 405 Kinase 36: EGFR P00533 405 Kinase 37: PDGFRB P09619 405

Kinase 38: FLT3 P36888 404 Kinase 39: TXK P42681 403 Kinase 40: SRM (SRMS) Q9H3Y6 399 Kinase 41: BMX P51813 398 Kinase 42: RET P07949 398 Kinase 43: LCK P06239 397 Kinase 44: BLK P51451 395 Kinase 45: ALK Q9UM73 394 Kinase 46: Flt4 (VEGFR3) P35918 394 Kinase 47: ITK Q08881 391 Kinase 48: LTK P29376 385 Kinase 49: KDR P35968 375 Kinase 50: TIE2 (TEK) Q02763 363 The top 50 human protein kinases that are likely to phosphorylate ASC Tyr146 as determined with PhosphoNET (http://www.phosphonet.ca/) based on Kinase Predictor V2 Score. The scores are provided by using kinase substrate prediction algorithm developed at Kinexus.